SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-172318
Filing Date
2015-05-05
Accepted
2015-05-05 17:02:15
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d911187d10q.htm 10-Q 406608
2 EX-10.4 d911187dex104.htm EX-10.4 76486
3 EX-31.1 d911187dex311.htm EX-31.1 8376
4 EX-31.2 d911187dex312.htm EX-31.2 8383
5 EX-32.1 d911187dex321.htm EX-32.1 4879
  Complete submission text file 0001193125-15-172318.txt   4917548

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgnt-20150331.xml EX-101.INS 617134
7 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20150331.xsd EX-101.SCH 47979
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20150331_cal.xml EX-101.CAL 88125
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20150331_def.xml EX-101.DEF 166640
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20150331_lab.xml EX-101.LAB 387615
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20150331_pre.xml EX-101.PRE 287390
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 15833877
SIC: 2834 Pharmaceutical Preparations